Opinion: FDA commissioner: ‘Smarter,’ real-time clinical trials could transform drug development
Stat News • 4/28/2026
Summary
FDA Commissioner states that "smarter," real-time clinical trials could transform drug development. For the first time, FDA regulators will be able to see what’s happening in a clinical trial by looking at endpoints in the cloud as they occur.
Advertisement
Lindy Score Breakdown (V4.2)
1h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
Stat News • Today
Opinion: Patients seeking mental health treatment are not commodities
Stat News • 1 day ago
STAT+: Google clinical director says AI can be a ‘bridge’ for people having a mental health crisis
Stat News • Today
STAT+: Veradermics’ hair loss drug succeeds in late-stage trial
Stat News • 1 day ago
Opinion: It’s time to seize the rare bipartisan opening to address microplastics
Stat News • Today
Opinion: Why do discussions about ‘brain health’ ignore mental illness?
Stat News • Today
Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racism
Stat News • 1 day ago
STAT+: Google’s clinical director on AI challenges
Stat News • Today
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
Stat News • 1 day ago
Fauci adviser David Morens indicted for concealing emails, avoiding records requests
Stat News • Today
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1+ months
STAT+: Trump budget’s ‘America First’ drug policy proposals
Stat News • 3 weeks ago
STAT+: Pharmalittle: We’re reading about Trump and drug prices, biotechs pushing back, and more
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 weeks ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 1 week ago
STAT+: Trump is getting more credit than Biden for efforts to lower drug prices
Stat News • 1+ months
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Stat News • 2+ months